Status:
UNKNOWN
CBT and Quality of Life of People With HIV, COVID-19 and Anxiety or Depression
Lead Sponsor:
Universidad Peruana Cayetano Heredia
Collaborating Sponsors:
Hospital Nacional Alberto Sabogal Sologuren
University of Minnesota
Conditions:
Quality of Life
Anxiety
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Experimental open-label randomized clinical trial to determine the effect of virtual Cognitive Behavioral Therapy (CBT) on the quality of life of patients with HIV, COVID-19 and anxiety or depression....
Detailed Description
Introduction: Confrontational measures such as social isolation and confinement due to the COVID-19 pandemic and the experience of illness have affected people's emotional health by generating or exac...
Eligibility Criteria
Inclusion
- Patients affiliated with Social Security.
- HIV patients diagnosed with COVID-19, anxiety or depression.
- Have a telephone to contact them.
- Family member or adult caregiver of the patient selected for the study and who previously authorized the invitation to the family member or caregiver to participate in the study.
Exclusion
- Difficulty to read and to write
- Being currently in psychotherapy
- Clinical diagnoses of neurocognitive or psychotic disorders
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2022
Estimated Enrollment :
182 Patients enrolled
Trial Details
Trial ID
NCT05185921
Start Date
March 1 2022
End Date
June 1 2022
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Nacional Alberto Sabogal Sologuren
Lima, Peru